USPSTF breast cancer chemoprevention recommendations: We’re in this togetherSeptember 23, 2013Breast Cancer
FDA advisory panel backs approval of neoadjuvant pertuzumab for breast cancerSeptember 13, 2013Breast Cancer
Perioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situSeptember 5, 2013Breast Cancer
No increase in cardiovascular risk seen after radiation therapy for DCIS September 4, 2013Breast Cancer
Long-term amenorrhea risk no higher for premenopausal breast cancer patients with BRCA mutationsAugust 27, 2013Breast Cancer
